Physician profile
Debdut Biswas
NPI 1265660534
$56,260.40
in general payments reported to CMS, 2019-2025
11 companies · $21K in 2025
The $21K reported for 2025 was more than what 96% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $586 · 2021: $137 · 2023: $20K · 2024: $14K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $50K · Travel and Lodging: $4,611 · Food and Beverage: $905 · Long Term Medical Supply Or Device Loan: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $49,700.00 |
| Travel and Lodging | $4,610.99 |
| Food and Beverage | $905.26 |
| Long Term Medical Supply Or Device Loan | $146.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Skeletal Dynamics INC | $55,175.89 | 2019-2025 | Implate, Align, Geminus |
| Medwest Associates | $586.00 | 2020 | |
| Integra Lifesciences Corporation | $164.55 | 2023-2024 | Acell, Tenoglide |
| Exsomed Corporation | $101.17 | 2021 | |
| Bioventus LLC | $76.43 | 2019 | |
| Djo, LLC | $46.89 | 2019 | |
| Osteomed LLC | $32.29 | 2019 | |
| Kerecis Limited | $27.64 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Janssen Pharmaceuticals, INC | $21.69 | 2021 | |
| Acera Surgical, INC. | $14.52 | 2021 | |
| Depuy Synthes Sales INC. | $13.33 | 2023 | Orthovisc, Monovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debdut Biswas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.